Sign Up Today and Learn More About Guardant Health Stock
Invest in or calculate the value of your shares in Guardant Health or other pre-IPO companies through EquityZen's platform.
About Guardant Health Stock
Founded
2012
Headquarters
Redwood City, CA, US
Total Funding
515M
Industries
Science and Engineering, Health Care, Biotechnology
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.
Guardant Health Press Mentions
Stay in the know about the latest news on Guardant Health
Guardant Health (NASDAQ:GH) Coverage Initiated by Analysts at Bank of America
Fairfield Current • Nov 06, 2018
October's winners & losers: Growth IPOs still fly high
Nasdaq • Nov 01, 2018
Guardant Health, Inc. (GH) moves -0.38% below SMA-50
Nasdaq Place (press release) • Oct 31, 2018
These 14 startups — endorsed by the seed-stage investment firm Pear — just hit the fundraising trail
TechCrunch • Oct 28, 2018
Cancer blood-testing company Guardant Health files for IPO
MarketWatch • Sep 06, 2018
Investors in Guardant Health
Discover investors in Guardant Health stock and explore their portfolio companies
Guardant Health Management
Leadership team at Guardant Health
Chief Executive Officer
Helmy Eltoukhy
Chief Financial Officer
Derek Bertocci
Join now and verify your accreditation status to gain access to:
- Guardant Health current valuation
- Guardant Health stock price
- Available deals in Guardant Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Guardant Health Stock
How to invest in Guardant Health stock?
Accredited investors can buy pre-IPO stock in companies like Guardant Health through EquityZen funds. These investments are made available by existing Guardant Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Guardant Health stock?
Shareholders can sell their Guardant Health stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
